Avecia
Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production. Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH. In 2016 Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals. Avecia was organized with a biologics business line and the oligonucleotide business line. In 2009, Avecia Biologics Limited based in Billingham, UK was acquired by Merck and was later part of Fujifilm Diosynth Biotechnologies.